Hippocampal nuclear factor kappa B accounts for stress‐induced anxiety behaviors via enhancing neuronal nitric oxide synthase (nNOS)‐carboxy‐terminal PDZ ligand of nNOS‐Dexras1 coupling - Zhu - 2018 - Journal of Neurochemistry - Wiley
Nuclear factor‐kappa β as a therapeutic target for Alzheimer's disease - Jha - 2019 - Journal of Neurochemistry - Wiley Online Library
IJMS | Free Full-Text | Small Molecule NF-κB Pathway Inhibitors in Clinic
Meditation experience predicts negative reinforcement learning and is associated with attenuated FRN amplitude | SpringerLink
Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease - ScienceDirect
Nuclear factor-kappa B (NF-κB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases - ScienceDirect
Nuclear factor-kappa B (NF-κB) inhibition as a therapeutic target for plant nutraceuticals in mitigating inflammatory lung diseases - ScienceDirect
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Insights into the mechanism of natural terpenoids as NF-κB inhibitors: an overview on their anticancer potential | Experimental oncology